Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Abbott presents HIV RNA-reducing drug combinations

July 12, 1996

Enzo Biochem, St. Luke's collaborate on gene therapy for AIDS

July 5, 1996

Telomere length may reflect disease progression in AIDS patients

July 5, 1996

RiboGene licenses anti-HIV compounds from Warner-Lambert

July 5, 1996

Vistide approved in U.S.

July 5, 1996

Various research groups announce independent discovery of receptor for HIV infection

July 5, 1996

CryptoGam demonstrates clear antimicrobial effect in clinical trial

July 5, 1996

Synovir clinical program expanded

July 5, 1996

Phase III trials of Alferon N Injection initiated in HIV-positive patients

July 5, 1996

CPMP approves saquinavir for marketing

July 5, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...
DEE-lightful: Praxis’ phase II results allow stock to flex its muscle
BioWorld
Positive efficacy results led to Praxis Precision Medicines Inc.’s phase II Embold study in developmental and epileptic encephalopathies (DEEs) being halted...